Dual Diagnosis Treatment Ctr. v. Centene Corporation

Good Law
United States Court of Appeals for the Ninth CircuitAugust 15, 202221-55962California1,295 words

Opinion

Opinion

NOT FOR PUBLICATION FILED

UNITED STATES COURT OF APPEALS AUG 15 2022

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

FOR THE NINTH CIRCUIT

DUAL DIAGNOSIS TREATMENT No. 21-55962 CENTER, INC., a California corporation; et al., D.C. No. 2:20-cv-04112-SB-PVC Plaintiffs-Appellants,

v. MEMORANDUM*

CENTENE CORPORATION, a Delaware corporation; et al.,

Defendants-Appellees,

and

LIANN GOHARI; et al.,

Defendants.

and

LAST CHANCE FUNDING INC.;

FLORENTINE HOLDING COMPANY V,

LLC,

Claimants,

Appeal from the United States District Court for the Central District of California Stanley Blumenfeld, Jr., District Judge, Presiding

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. Argued and Submitted August 2, 2022 Pasadena, California

Before: CALLAHAN and H. THOMAS, Circuit Judges, and HUMETEWA,** District Judge.

Plaintiffs appeal the dismissal of their Third Amended Complaint (TAC)

with prejudice. We have jurisdiction under 28 U.S.C. § 1291. We affirm in…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.